NCT Number: NCT05480644
The purpose of this protocol is to create a repository of blood samples from patients diagnosed with primary and metastatic brain tumors who are being seen in the Department of Radiation Oncology at Duke Cancer Center.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Durham, North Carolina, 27710, United States
Location status: Recruiting
Eugene Vaios, MD MBA
PRINCIPAL_INVESTIGATOR
Kaitlin Bailey, RN
CONTACT
Linda Kaltenbach, PhD
CONTACT
Scott Flody, MD PhD
PRINCIPAL_INVESTIGATOR
Zach Reitman, MD PhD
PRINCIPAL_INVESTIGATOR
Repository blood samples will be used to study the association of circulating biomarkers with radiation therapy outcomes.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 6 weeks post radiation therapy
reported as mean +/- standard deviation
Contact information is provided by the study sponsor or research team.
Kaitlin Bailey, RN OCN
CONTACT
Linda Kaltenbach, PhD
CONTACT
Duke University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06185686
Brain Diseases, Brain Neoplasms
St Louis, Missouri, United States
View Trial DetailsNCT03213002
Astrocytoma, Brain Cancer
New York, United States
View Trial DetailsNCT07179328
Astrocytoma, Brain Diseases
Toronto, Ontario, Canada
View Trial DetailsNCT05831631
Brain Diseases, Brain Neoplasms
Milan, Italy
View Trial Details